Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study
Journal of Hepatocellular Carcinoma · 2026-09 · Volume 13 · 1-14
DOI: 10.2147/jhc.s625046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-09. Verfasst von Shanzhi Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Vascular Surgery I, Hunan Cancer Hospital, Changsha, 410000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Interventional Vascular Surgery I, Hunan Cancer Hospital, Changsha, 410000, People's Republic of China.
- Department of Interventional Vascular Surgery II, Hunan Cancer Hospital, Changsha, 410000, People's Republic of China.
Zitieren
APA
Gu, S., Zhao, Y., Yan, H., Li, M., Li, G., Huang, M., Xiong, Z., & Huang, B. (2026). Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study. Journal of Hepatocellular Carcinoma, Volume 13, 1-14. https://doi.org/10.2147/jhc.s625046
Vancouver
Gu S, Zhao Y, Yan H, Li M, Li G, Huang M, et al. Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-14. doi:10.2147/jhc.s625046
BibTeX
@article{Gu2026,
author = {Gu, Shanzhi and Zhao, Yang and Yan, Haixiong and Li, Muzi and Li, Guowen and Huang, Manping and Xiong, Zhengping and Huang, Bin},
title = {Nivolumab Plus Lenvatinib and Intra-Arterial Locoregional Therapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Real-World Study},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--14},
doi = {10.2147/jhc.s625046}
}
EUVIMED